Regina Margaret Graul is of Cyclerion Therapeutics, Inc.. Currently has a direct ownership of 100,303 shares of CYCN, which is worth approximately $267,809. The most recent transaction as insider was on Jan 01, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
0% 12M change
Total Value Held $267,809

Regina Margaret Graul Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 33.27%
100,303 Common Stock
RMG

Regina Margaret Graul

Cambridge, MA

Track Institutional and Insider Activities on CYCN

Follow Cyclerion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCN shares.

Notify only if
Any

Insider Trading

Get notified when an Cyclerion Therapeutics, Inc. insider buys or sells CYCN shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Cyclerion Therapeutics, Inc.

Track Activities on CYCN